Corpus Intelligence IC Memo — PROVIDENCE SEWARD MEDICAL & CARE CEN 2026-04-26 06:38 UTC
IC Memo — PROVIDENCE SEWARD MEDICAL & CARE CEN
Investment Committee Memorandum | AK | 6 beds | Grade C | EBITDA uplift $2.2M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

PROVIDENCE SEWARD MEDICAL & CARE CEN

CCN 021302 | KENAI PENINSULA BOROUGH, AK | 6 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

PROVIDENCE SEWARD MEDICAL & CARE CEN is a 6-bed rural/critical access in KENAI PENINSULA BOROUGH, AK with $29.5M in net patient revenue and a 17.5% operating margin. The hospital serves a payer mix of 65.7% Medicare, 17.4% Medicaid, and 16.9% commercial.

Thesis: Turnaround. Our ML models identify $2.2M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 17.5% to 24.9% (+736bps).

Net Revenue HCRIS$29.5M
Current EBITDA COMPUTED$5.2M
Operating Margin COMPUTED17.5%
Occupancy HCRIS17.6%
Revenue / Bed COMPUTED$4.9M
Net-to-Gross HCRIS66.1%
Distress Probability ML58.7%

2. Market Context & Competitive Position

24
AK Hospitals
-2.1%
State Median Margin
114
Comparable Hospitals

AK has 24 Medicare-certified hospitals with a median operating margin of -2.1%. The target's margin of 17.5% places it above the state median. Among 114 size-comparable peers (3-12 beds), the median margin is -8.7%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (3-12), prioritizing same-state peers. 114 hospitals in the comp set.

HospitalStateBedsRevenueMargin
PROVIDENCE SEWARD MEDICAL & CA (Target)AK6$29.5M17.5%
WENATCHEE VALLEY HOSPITALWA11$277.5M-4.9%
FRANCISCAN HEALTH HAMMONDIN10$117.7M-4.3%
OCONTO HOSPITAL & MEDICAL CENTWI10$80.4M1.1%
SUMMIT PACIFIC MEDICAL CENTERWA10$73.6M9.1%
PHYSICIANS MEDICAL CENTERIN10$60.0M24.9%
SAMUEL SIMMONDS MEMORIAL HOSPIAK10$57.8M-50.0%
INSTITUTE FOR ORTHOPAEDIC SURGOH12$55.6M39.5%
JOYCE EISENBERG KEEFER MEDICALCA10$52.9M18.8%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.2M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$620K+210bp18mo
Cost to Collect4.5%2.5%$591K+200bp12mo
Denial Rate Reduction12.0%6.5%$585K+198bp12mo
A/R Days Reduction5200.0%3800.0%$359K+122bp9mo
Clean Claim Rate88.0%96.0%$19K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$620K
Cost to Collect
$591K
Denial Rate Reduction
$585K
A/R Days Reduction
$359K
Clean Claim Rate
$19K
Total EBITDA Uplift$2.2M
Current EBITDA$5.2M
+ RCM Uplift+$2.2M
Pro Forma EBITDA$7.3M
Current Margin17.5%
Pro Forma Margin24.9%
WC Released (1x)$1.1M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$8.0M$55.9M7.02x47.6%
Base (11x exit)10.0x11.0x$8.0M$64.0M8.04x51.7%
Bull Case9.0x11.0x$7.2M$73.8M10.30x59.4%
Bull (12x exit)9.0x12.0x$7.2M$82.6M11.53x63.1%
Bear Case11.0x10.0x$8.8M$42.4M4.84x37.1%
Bear (11x exit)11.0x11.0x$8.8M$49.5M5.65x41.4%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumHeavy Medicare dependenceMedicare comprises 65.7% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement
MediumLow occupancyAt 17.6%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 58.7% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 114 hospitals with 3-12 beds
  • Same-state prioritization (n=5)
  • Comp margins: P25=-22.5% / P50=-8.7% / P75=2.4%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.